| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.002 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.004 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.083 | 0.006 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.085 | 0.008 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.01 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |